Loading insider details...
Beta
Latest Form 4 (Aug 12, 2026): Conversion of 494,800 LTGO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Latigo Biotherapeutics, Inc. (LTGO) | Conversion | 494,800 | n/a |
| Aug 7, 2026 | Attovia Therapeutics, Inc. (ATTO) | Conversion | 782,855 | n/a |
| Sep 14, 2021 | Translate Bio, Inc. (TBIO) | Purchase | 51,467,612 | $1.96B |
| Aug 3, 2021 | Icosavax, Inc. (ICVX) | Conversion | 3,088,502 | n/a |
| Jul 29, 2020 | Inozyme Pharma, Inc. (INZY) | Conversion | 438,875 | n/a |
| Jun 11, 2020 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 120,234 | $71.84M |
| May 29, 2020 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 20,421,899 | n/a |
| Mar 11, 2020 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 128,914 | $63.12M |
| Sep 12, 2019 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 172,904 | $48.61M |
| Mar 13, 2019 | REGENERON PHARMACEUTICALS INC (REGN) | Sale | 131,115 | $54.04M |